Abstrait

Editorial Note on Gut Microbiota Diversity

Jennifer Chennat

Acute myeloid leukemia (AML) in depth chemotherapy blended with broad-spectrum antibiotics ends in intestine microbiota dysbiosis selling pathological situations and an accelerated prevalence of complications. Here we file findings from a segment II single-arm, multicenter examine comparing autologous fecal microbiota transfer (AFMT) in 25 AML sufferers dealt with with in depth chemotherapy and antibiotics (ClinicalTrials.gov number: NCT02928523). The co-number one consequences of the examine are to assess the efficacy of AFMT in dysbiosis correction and multidrug-resistant Microorganism eradication.